More donors or more delayed graft function? A cost-effectiveness analysis of DCD kidney transplantation

Clinical Transplantation

Volumn 27, Issue 2, 2013, Pages 289-296

  Snyder, Rebecca A ^a,b   Moore, Deonna R ^a   Moore, Derek E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cost benefit analysis; Economics, medical; Kidney transplantation; Quality adjusted life years; Tissue and organ procurement

Indexed keywords

ARTICLE; BRAIN DEATH; CADAVER DONOR; CHRONIC PATIENT; COLD ISCHEMIA; COST EFFECTIVENESS ANALYSIS; DELAYED GRAFT FUNCTION; GRAFT SURVIVAL; HEALTH CARE COST; HEALTH STATUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LONG TERM SURVIVAL; ORGAN DONOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

BRAIN DEATH; COST-BENEFIT ANALYSIS; DEATH; DECISION SUPPORT TECHNIQUES; DELAYED GRAFT FUNCTION; DONOR SELECTION; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MARKOV CHAINS; MODELS, ECONOMIC; QUALITY-ADJUSTED LIFE YEARS; RENAL DIALYSIS; TISSUE DONORS; UNITED STATES; WAITING LISTS;

EID: 84876094735     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12073     Document Type: Article

References (46)

1. Evans RW, Manninen DL, Garrison LP Jr et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985: 312: 553.
2. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
3. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville: MD.
4. Ledinh H, Bonvoisin C, Weekers L et al. Results of kidney transplantation from donors after cardiac death. Transplant Proc 2010: 42: 2407.
5. Snoeijs MG, Winkens B, Heemskerk MB et al. Kidney transplantation from donors after cardiac death: a 25-year experience. Transplantation 2010: 90: 1106.
6. Singh RP, Farney AC, Rogers J et al. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant 2011: 25: 255.
7. Wells AC, Rushworth L, Thiru S et al. Donor kidney disease and transplant outcome for kidneys donated after cardiac death. Br J Surg 2009: 96: 299.
8. Rudich SM, Kaplan B, Magee JC et al. Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation 2002: 74: 1715.
9. Weber M, Dindo D, Demartines N, Ambuhl PM, Clavien PA. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002: 347: 248.
10. Cooper JT, Chin LT, Krieger NR et al. Donation after cardiac death: the University of Wisconsin experience with renal transplantation. Am J Transplant 2004: 4: 1490.
11. Barlow AD, Metcalfe MS, Johari Y, Elwell R, Veitch PS, Nicholson ML. Case-matched comparison of long-term results of non-heart beating and heart-beating donor renal transplants. Br J Surg 2009: 96: 685.
12. Eggers P. Comparison of treatment costs between dialysis and transplantation. Semin Nephrol 1992: 12: 284.
13. Roberts SD, Maxwell DR, Gross TL. Cost-effective care of end-stage renal disease: a billion dollar question. Ann Intern Med 1980: 92(2 Pt 1): 243.
14. Whiting JF, Woodward RS, Zavala EY et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation 2000: 70: 755.
15. Inadomi JM. Decision analysis and economic modelling: a primer. Eur J Gastroenterol Hepatol 2004: 16: 535.
16. Birkmeyer JD, Liu JY. Decision analysis models: opening the black box. Surgery 2003: 133: 1.
17. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 1996: 276: 1339.
18. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996: 276: 1253.
19. United States Department of Labor-Bureau of Labor Statistics. Wages by Area and Occupation [database on the Internet]. Statistics USDoL-BoL. [cited March 11, 2011]. Available from: http://www.bls.gov/bls/blswage.htm.
20. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996: 276: 1172.
21. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977: 296: 716.
22. Torrance GW. Preferences for health outcomes and cost-utility analysis. Am J Manag Care 1997: 3 (Suppl.): S8.
23. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985: 5: 157.
24. Saidi RF, Elias N, Kawai T et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant 2007: 7: 2769.
25. Brook NR, Nicholson ML. Kidney transplantation from non heart-beating donors. Surgeon 2003: 1: 311.
26. Cohen B, Smits JM, Haase B, Persijn G, Vanrenterghem Y, Frei U. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005: 20: 34.
27. Ledinh H, Meurisse N, Delbouille MH et al. Contribution of donors after cardiac death to the deceased donor pool: 2002 to 2009 University of Liege experience. Transplant Proc 2010: 42: 4369.
28. Cohen DJ, St Martin L, Christensen LL, Bloom RD, Sung RS. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006: 6(5 Pt 2): 1153.
29. Doshi MD, Hunsicker LG. Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007: 7: 122.
30. Farney AC, Singh RP, Hines MH et al. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg 2008: 206: 1028; discussion 37.
31. Jochmans I, Moers C, Smits JM et al. Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg 2010: 252: 756.
32. Stratta RJ, Rohr MS, Sundberg AK et al. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality? Ann Surg 2006: 243: 594; discussion-3.
33. Avramovic M, Stefanovic V. Health-related quality of life in different stages of renal failure. Artif Organs 2012: 36: 581.
34. Haller M, Gutjahr G, Kramar R, Harnoncourt F, Oberbauer R. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant 2011: 26: 2988.
35. Hirth RA, Held PJ, Orzol SM, Dor A. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res 1999: 33: 1567.
36. Menzin J, Lines LM, Weiner DE et al. A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy. Pharmacoeconomics 2011: 29: 839.
37. Painter P, Krasnoff JB, Kuskowski M, Frassetto L, Johansen K. Effects of modality change on health-related quality of life. Hemodial Int 2012: 16: 377.
38. Rajan M, Lai KC, Tseng CL et al. Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes. Qual Life Res 2012: Mar 6 [Epub ahead of print].
39. Whiting JF, Zavala EY, Alexander JW, First MR. The cost-effectiveness of transplantation with expanded donor kidneys. Transplant Proc 1999: 31: 1320.
40. Barnieh L, Manns BJ, Klarenbach S, McLaughlin K, Yilmaz S, Hemmelgarn BR. A description of the costs of living and standard criteria deceased donor kidney transplantation. Am J Transplant 2011: 11: 478.
41. Klarenbach S, Barnieh L, Gill J. Is living kidney donation the answer to the economic problem of end-stage renal disease? Semin Nephrol 2009: 29: 533.
42. Kontodimopoulos N, Niakas D. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy. Health Policy 2008: 86: 85.
43. Buchanan PM, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant 2008: 8: 2391.
44. Machnicki G, Lentine KL, Salvalaggio PR, Burroughs TE, Brennan DC, Schnitzler MA. Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Arch Med Sci 2011: 7: 278.
45. Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. Am J Transplant 2004: 4: 216.
46. Wong G, Howard K, Chapman JR et al. Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS ONE 2012: 7: e29591.